Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple system atrophy
Symptom C0242422|parkinsonism
Sentences 7
PubMedID- 23903508 multiple system atrophy with predominant parkinsonism (msa-p) usually shows poor responsiveness to dopaminergic medications.
PubMedID- 24179801 In multiple system atrophy with predominant parkinsonism (msa-p), several voxel-based morphometry (vbm) studies have revealed gray matter loss; however, the white matter volume changes have been rarely reported.
PubMedID- 26324212 Background: the frontal assessment battery (fab) has been suggested as a useful tool in the differential diagnosis of progressive supranuclear palsy (psp) from parkinson's disease (pd) and multiple system atrophy with parkinsonism (msa-p).
PubMedID- 21597312 Case presentation: a 54-year-old male patient presenting probable multiple system atrophy with predominant parkinsonism who underwent bilateral deep brain stimulation (dbs) of the pedunculopontine nucleus (ppn) is presented.
PubMedID- 25413272 Objective: although a correct diagnosis is important for appropriate management, accurately differentiating between multiple system atrophy with predominant parkinsonism (msa-p) and parkinson's disease (pd) is often difficult because of similarities in the early-stage symptoms.
PubMedID- 22051807 Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.
PubMedID- 24619850 Background: the putaminal abnormalities detected on 1.5 t magnetic resonance imaging (mri), such as putaminal atrophy, slit-like hyperintense rim, and hypointensity in the putamen on t2-weighted (t2w) imaging are important signs on differentiating multiple system atrophy with parkinsonism (msa-p) from parkinson's disease (pd).

Page: 1